Octave Bioscience logo

Octave Bioscience Funding & Investors

Menlo Park, CA

Octave Bioscience is an early-stage molecular diagnostics company focused on neurodegenerative diseases and conditions. The company was co-founded by Melinda Thomas and William Hagstrom in 2013. Octave Bioscience is headquartered in Menlo Park, California, United States.

octavebio.com

Total Amount Raised: $91,000,072

Octave Bioscience Funding Rounds

  • Grant

    $10,000,000

    Grant Investors

    The Michael J. Fox Foundation for Parkinson's Research
  • Series B

    $32,500,070

    Series B Investors

    Novartis
    Deerfield Management
    The Blue Venture Fund
    Hikma Ventures
    Merck
    Northpond Ventures
    Echo Health Ventures
    S32
    Intermountain Ventures
    Casdin Capital
  • Series B

    $32,000,000

    Series B Investors

    Northpond Ventures
    S32
    Casdin Capital
    Echo Health Ventures
    Deerfield Management
  • Series A

    $14,000,000

    Series A Investors

    The Blue Venture Fund
    S32
    Echo Health Ventures
  • Seed

    $2,500,000

Funding info provided by Diffbot.